FIELD: medicine. SUBSTANCE: desired product having essential formula C23H36N4Cl2O2 is prepared by reaction of DL-camphorimide with 8-(2-pyridyl)-2-aza-5-azoniaspiro. Reaction is carried out in absolute dimethylformamide in the presence of potassium carbonate. The process is followed by treatment with HCl. EFFECT: creates novel compound having various psychotropic effect. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
NOVEL USING 2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]-CHROMAN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS | 2002 |
|
RU2297833C2 |
1-PROPYL-2-OXO-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID DIETHYLAMINOETHYLAMIDE HYDROCHLORIDE SHOWING ANESTHETIC, ANTIARRHYTHMIC, ANTIOXIDANT, ANTIMICROBIAL AND FUNGICIDAL ACTIVITY | 1990 |
|
RU1774624C |
DERIVATIVES OF 3,4-BIS-(FURAZAN-3-YL)FUROXANE PRODUCING NITROGEN OXIDE, ACTIVATING GUANYLATE CYCLASE SOLUBLE FORM, INHIBITING PLATELET AGGREGATION AND ELICITING SPASMOLYTIC, VASODILATING, HYPOTENSIVE EFFECT AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2240321C2 |
SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS AND USE | 2012 |
|
RU2611007C2 |
1,1,1-TRIFLUORO-3-HYDROXYPROPANE-2-YLCARBAMATE DERIVATIVES AS MAGL INHIBITORS | 2018 |
|
RU2720203C1 |
Authors
Dates
1995-12-10—Published
1990-10-29—Filed